Coronary artery disease risk prediction by combined stratification of low-density lipoprotein-cholesterol and high-density lipoprotein-cholesterol levels across different glucose statuses

被引:0
|
作者
Yachida, Junko [1 ,2 ]
Fujihara, Kazuya [1 ]
Yamada, Mayuko Harada [1 ]
Kobayashi, Ayako [1 ,2 ]
Khin, Lay Mon [1 ]
Takizawa, Hiroki [1 ]
Yamamoto, Masahiko [1 ]
Kitazawa, Masaru [1 ]
Matsubayashi, Yasuhiro [1 ]
Yamada, Takaho [1 ]
Kodama, Satoru [1 ]
Sone, Hirohito [1 ]
机构
[1] Niigata Univ, Dept Hematol Endocrinol & Metab, Fac Med, Niigata, Japan
[2] Niigata Coll Nursing, Joetsu, Japan
来源
DIABETES OBESITY & METABOLISM | 2024年 / 26卷 / 12期
基金
日本学术振兴会;
关键词
cardiovascular disease; coronary artery disease; glucose abnormalities; high-density lipoprotein cholesterol; low-density lipoprotein cholesterol; STATIN-TREATED PATIENTS; APOLIPOPROTEIN-A-I; HEART-DISEASE; CARDIOVASCULAR-DISEASE; HDL CHOLESTEROL; INSULIN-RESISTANCE; TOLERANCE STATUS; LDL CHOLESTEROL; MORTALITY; JAPAN;
D O I
10.1111/dom.15956
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: To investigate the association between low-density lipoprotein-cholesterol (LDL-C) levels and coronary artery disease (CAD) incidence based on combining high-density lipoprotein-cholesterol (HDL-C) levels and glucose status. Materials and Methods: In this retrospective cohort study, we used data from a nationwide claims database (1,524,289 individuals without a history of CAD or familial hypercholesterolaemia; 2008-2019). Cox proportional hazards modelling identified the risk of incident CAD by a novel combination of four HDL-C levels, seven LDL-C levels and glucose status. Results: During the follow-up period (mean: 5.5 years), 8301 (0.99/1000 person-years) events occurred. The risk of CAD increased from lower LDL-C levels accompanied by lower HDL-C levels regardless of the glucose status. Using the most favourable levels of HDL-C and LDL-C (i.e. 60-99 mg/dL and <80 mg/dL, respectively) as references, the hazard ratios (95% confidence interval) for the group with HDL-C levels <40 mg/dL and LDL-C levels <80 mg/dL were 2.74 (1.47-5.11), 2.52 (1.30-4.91) and 2.85 (1.68-4.84) for normoglycaemia, borderline glycaemia and diabetes, respectively. Comparison of the most favourable levels of HDL-C and LDL-C with their least favourable levels (i.e. <40 mg/dL and 180-199 mg/dL, respectively) revealed that the risk of new-onset CAD exhibited a 19-, nine- and seven-fold increase in individuals with normoglycaemia, borderline glycaemia and diabetes, respectively. Conclusions: To prevent CAD, LDL-C levels should be strictly controlled in patients with low HDL-C levels regardless of glucose tolerance. Individualized treatment, which involves setting target LDL-C levels based on glucose tolerance and HDL-C values, is required.
引用
收藏
页码:5845 / 5856
页数:12
相关论文
共 50 条
  • [31] STUDIES ON LIPOPROTEIN AND ADRENAL STEROIDOGENESIS .1. ROLES OF LOW-DENSITY LIPOPROTEIN-CHOLESTEROL AND HIGH-DENSITY LIPOPROTEIN-CHOLESTEROL IN STEROID-PRODUCTION IN CULTURED HUMAN ADRENOCORTICAL-CELLS
    HIGASHIJIMA, M
    NAWATA, H
    KATO, K
    IBAYASHI, H
    ENDOCRINOLOGIA JAPONICA, 1987, 34 (05): : 635 - 645
  • [32] Influence of risk factors on peripheral and cerebrovascular disease in men with coronary artery disease, low high-density lipoprotein, cholesterol levels, and desirable low-density lipoprotein cholesterol levels
    Papademetriou, V
    Narayan, P
    Rubins, H
    Collins, D
    Robins, S
    AMERICAN HEART JOURNAL, 1998, 136 (04) : 734 - 740
  • [33] Accuracy and Clinical Impact of Estimating Low-Density Lipoprotein-Cholesterol at High and Low Levels by Different Equations
    Sampson, Maureen
    Wolska, Anna
    Cole, Justine
    Zubiran, Rafael
    Otvos, James D.
    Meeusen, Jeff W.
    Donato, Leslie J.
    Jaffe, Allan S.
    Remaley, Alan T.
    BIOMEDICINES, 2022, 10 (12)
  • [34] AMP-kinase α2 subunit gene PRKAA2 variants are associated with total cholesterol, low-density lipoprotein-cholesterol and high-density lipoprotein-cholesterol in normal women
    Spencer-Jones, N. J.
    Ge, D.
    Snieder, H.
    Perks, U.
    Swaminathan, R.
    Spector, T. D.
    Carter, N. D.
    O'Dell, S. D.
    JOURNAL OF MEDICAL GENETICS, 2006, 43 (12) : 936 - 942
  • [35] High density lipoprotein-cholesterol changes in children with high cholesterol levels at birth
    Sara Bastida
    Francisco J. Sánchez-Muniz
    Rafael Cuena
    Sagrario Perea
    Angel Aragonés
    European Journal of Pediatrics, 2002, 161 : 94 - 98
  • [36] High density lipoprotein-cholesterol changes in children with high cholesterol levels at birth
    Bastida, S
    Sánchez-Muniz, FJ
    Cuena, R
    Perea, S
    Aragonés, A
    EUROPEAN JOURNAL OF PEDIATRICS, 2002, 161 (02) : 94 - 98
  • [37] High-density lipoprotein-cholesterol, reverse cholesterol transport, and cardiovascular risk: a tale of genetics?
    Cimmino, Giovanni
    D'Amico, Chiara
    Ciccarelli, Giovanni
    Golino, Marco
    Morello, Alberto
    D'Elia, Saverio
    Marchese, Valeria
    Golino, Paolo
    CARDIOGENETICS, 2013, 3 (01) : 38 - 43
  • [38] The Triglyceride: High-Density Lipoprotein-Cholesterol Ratio in Prediction of Development of Atherosclerotic Disease Process
    Jani, Vishal
    Chang, Chi
    Hussain, Sayed
    Zaidat, Osama
    Kassab, Mounzer
    NEUROLOGY, 2012, 78
  • [39] STUDIES ON LIPOPROTEIN AND ADRENAL STEROIDOGENESIS .2. UTILIZATION OF LOW-DENSITY LIPOPROTEIN-CHOLESTEROL AND HIGH-DENSITY LIPOPROTEIN-CHOLESTEROL FOR STEROID-PRODUCTION IN FUNCTIONING HUMAN ADRENOCORTICAL ADENOMA CELLS IN CULTURE
    HIGASHIJIMA, M
    KATO, K
    NAWATA, H
    IBAYASHI, H
    ENDOCRINOLOGIA JAPONICA, 1987, 34 (05): : 647 - 657
  • [40] Total cholesterol/high-density lipoprotein cholesterol and low-density lipoprotein cholesterol/high-density lipoprotein cholesterol as predictors of coronary artery calcification assessed by multidetector computed tomography coronary angiography
    Seaoud, Elshaimaa Aly M. Elsadek
    Amin, Mohamed Ibrahim
    Abdelbasit, Mohamed Salah
    ARYA ATHEROSCLEROSIS, 2022, 18